Package 72426-818-99

{"route": ["ORAL"], "spl_id": "d5525891-2cfc-49bf-a684-5d5628dfb9bc", "openfda": {"nui": ["N0000193913", "N0000193914", "N0000008553", "N0000175911"], "unii": ["1EJ6Z6Q368", "EOR26LQQ24"], "rxcui": ["2283230", "2283236"], "spl_set_id": ["3fa2108c-0300-47b8-9d34-f762af7c93c6"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "pharm_class_epc": ["Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "pharm_class_moa": ["Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]"], "manufacturer_name": ["Esperion Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72426-818-03)", "package_ndc": "72426-818-03", "marketing_start_date": "20200309"}, {"sample": false, "description": "7 TABLET, FILM COATED in 1 BLISTER PACK (72426-818-99)", "package_ndc": "72426-818-99", "marketing_start_date": "20200309"}], "brand_name": "Nexlizet", "product_id": "72426-818_d5525891-2cfc-49bf-a684-5d5628dfb9bc", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]", "Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]", "Decreased Cholesterol Absorption [PE]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "product_ndc": "72426-818", "generic_name": "Bempedoic Acid and Ezetimibe", "labeler_name": "Esperion Therapeutics, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nexlizet", "active_ingredients": [{"name": "BEMPEDOIC ACID", "strength": "180 mg/1"}, {"name": "EZETIMIBE", "strength": "10 mg/1"}], "application_number": "NDA211617", "marketing_category": "NDA", "marketing_start_date": "20200309", "listing_expiration_date": "20271231"}